Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients. (Q54613838)

1 June 2018

title

Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients. (English)

1 reference

1 June 2018

author name string

A Amery

1

1 reference

1 June 2018

L Billiet

2

1 reference

1 June 2018

A Boel

3

1 reference

1 June 2018

R Fagard

4

1 reference

1 June 2018

T Reybrouck

5

1 reference

1 June 2018

J Willems

6

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 May 1976

1 reference

1 June 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

American Heart Journal

1 reference

1 June 2018

volume

91

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

page(s)

634-642

1 reference

1 June 2018

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Influence of age on the hemodynamic response to exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Central circulation during submaximal work preceded by heavy exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Comparison of the effects of propranolol and ICI 66082 in blocking the renin releasing effect of renal nerve stimulation in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980149-4

10.1016/S0002-8703(76)80149-4

7 January 2021

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018